OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Trustee’s Annual Report and Accounts North Bristol NHS Trust Charitable Funds

For the year ended 31 March 2023

North Bristol NHS Charitable Funds operates under the name Southmead Hospital Charity

Registered Charity Number: 1055900

SHC Annual Report 202212023

Content Page

Introduction ......................................................................................................................................................... 4 Chair’s message ................................................................................................................................................... 5 Objectives and activities ...................................................................................................................................... 6 Achievements and performance ......................................................................................................................... 7 Pioneering research ......................................................................................................................................... 7 Patient & family wellbeing .............................................................................................................................. 8 Staff wellbeing & training ................................................................................................................................ 8 Cutting-edge equipment ................................................................................................................................. 8 Enhancing buildings & spaces.......................................................................................................................... 9 Financial review ................................................................................................................................................. 11 Our future plans ................................................................................................................................................ 16 Structure, governance and Charity management ............................................................................................. 17 Statement of Trustee’s responsibilities in respect of the accounts .................................................................. 21 Independent auditor's report to the corporate trustee of North Bristol NHS Trust Charitable Funds ............. 22 Statement of financial activities ........................................................................................................................ 27 Balance sheet as at 31 March 2023 ................................................................................................................... 28 Cash flow statement .......................................................................................................................................... 29 Notes to the accounts ....................................................................................................................................... 30 Reference and administration details ............................................................................................................... 40

SHC Annual Report 2022/2023

Report of the Trustee: Introduction

Introduction

Southmead Hospital Charity, Registered Charity Number 1055900, is administered and managed by the sole Trustee, North Bristol NHS Trust as a corporate body, which is represented by the Trust Board of Directors.

The Charity’s annual report and accounts for the year ended 31 March 2023 have been prepared by the Corporate Trustee in accordance with FRS102 and the Statement of Recommended Practice for charities. Both the Chair of the Trust Board and the Non-Executive Directors are appointed by NHS England, and the Executive members of the Board are subject to recruitment by the NHS Trust Board. Members of the Trust Board and Southmead Hospital Charity Committee are not individual Trustees under charity law but act as agents on behalf of the Corporate Trustee.

SHC Annual Report 2022/2023

4

Report of the Trustee: Chair’s Message

Chair’s message

Southmead Hospital Charity (SHC) is proud to be the official charity of North Bristol NHS Trust (NBT). Our dedicated donors and fundraisers continue to passionately support our local NHS staff and services, and, because of them, we can bring world-class projects to life across our five key funding areas: pioneering research; patients & family wellbeing; staff wellbeing & training; cutting-edge equipment; and enhancing buildings & spaces.

Over the last year, we have worked closely with our NBT colleagues to deliver 520 projects to support patients, their families, and our 12,000-strong workforce. We have used donations to enhance patient care across our hospitals, resulting in £2,437k spend on projects, and committing a total of £3,631k to projects that span multiple years. Of course, we must acknowledge the cost-of-living crisis and the impact that rising costs are having on household budgets. Despite this difficult economic and fundraising climate, our donors have continued to give generously, helping us achieve an income of £1,695k.

Over the next year we will further progress our fundraising strategy, enhancing our donor stewardship plans to recognise the commitment of our wonderful supporters and ensuring they feel part of our NBT community. Our focus will be on securing major gifts and increasing the visibility of legacy giving to ensure we achieve unrestricted income and long-term sustainability which will deliver projects to support the health of people in Bristol, North Somerset, South Gloucestershire and beyond.

We have some exciting projects in the pipeline which will make our hospitals and services even greater; from a new flagship 3D design facility to make prosthetics and medical devices, to AI-assisted research into Parkinson’s Disease. Alongside these large projects, we’ll continue to support initiatives that bring comfort to patients and promote the wellbeing of our incredible staff.

We are so grateful to our donors and fundraisers for enabling us to play a part in helping our local NHS give the very best care to patients. I look forward to next year with anticipation knowing that there is so much more we will achieve together.

Richard Gaunt

Chair, Southmead Hospital Charity Committee Non-Executive Director, North Bristol NHS Trust

SHC Annual Report 2022/2023

5

Report of the Trustee: Objective and activities

Objectives and activities

The overall registered purpose of the Charity is to, ‘apply income for any charitable purpose relating to the National Health Service wholly or mainly for the services provided by North Bristol NHS Trust’. It is the responsibility of the Corporate Trustee to ensure that all donations and legacies are utilised strictly in accordance with the purpose for which they were given.

As the official charity of North Bristol NHS Trust (NBT), donations to us deliver world-class projects and comforting items over and above what the NHS funds. We work alongside the 12,000 staff at NBT and we aim to make life better for staff, patients, and their families by supporting projects across our five key areas:

NBT is home to Southmead Hospital, Cossham Hospital, the Bristol Centre for Enablement, South Bristol Dialysis Unit and retained services at Frenchay. It is the major trauma centre for the South West, and a regional specialist centre for neurosurgery, renal transplants and stroke services. Every year NBT treats one million patients from Bristol, North Somerset, South Gloucestershire and beyond.

SHC Annual Report 2022/2023

6

Report of the Trustee: Achievements and performance

Achievements and performance

After a difficult couple of years navigating Covid-19 and the restrictions it imposed, this financial year has seen the return of many of our fundraising events and activities. Emerging, however, into a cost-of-living crisis has had an inevitable impact on charitable giving. Despite this, we have been heartened by the response of our donors and fundraisers who continue to give so generously within their means. Once again, our Christmas Appeal – the main donation ask of the year – had a very positive response from committed donors raising more than £21k. As well as working with a local design agency to produce a more professional and cohesive appeal across traditional and digital channels, the concept of highlighting our hardworking, behind-the-scenes staff afforded us the opportunity to engage with multiple stakeholders in the Trust to incorporate different staff experiences, raising our profile with staff members. Continuing this theme, this year also saw the return of hospital activities including stalls and collections run by volunteers, and our monthly Bake Well bake sales in the Brunel building atrium. Besides the fundraising potential, these activities have enabled further engagement with our key audiences of grateful patients and families, and our 12,000-strong workforce.

Working alongside our fund holder colleagues, we’ve approved £3,631k of spend across 522 projects – with some ambitious projects spanning multiple financial years and having the potential to make a huge difference to patients and staff. Here are some examples of how donations have been spent across our five key funding areas:

Pioneering research: £432k

PhD success in brain tumour research £52k

Earlier this year Dr Amy Howell completed her PhD in the field of glioma research. Gliomas are a group of brain tumours, the most common and aggressive of which is glioblastoma. Amy’s research aimed to identify and validate risk factors for the onset of glioma, as well as explore targeted treatment options that could positively change the course of the disease in glioma patients. Her findings have been published in three peerreviewed journals and acknowledged for their valuable contribution to glioma research. Amy is now working as a post-doctoral researcher at the University of Bristol looking at risk factors for adverse pregnancy outcomes.

Lung Health at 30 Project £64k

The Lung Health @30 project is extending the world-leading ALSPAC clinic to help understand the origins of chronic lung disease, to include assessment of lung function and impact of COVID-19 on lung health.

SHC Annual Report 2022/2023

Report of the Trustee: Achievements and performance

Patient & family wellbeing: £624k

Critical care follow up service £77k

Following a successful trial, the ICU team rolled out a 12-month long critical care followup service for patients experiencing ongoing physical and psychological problems after their ICU admission.

Fresh Arts brings creativity and joy to patients £138k

A varied programme of art and music continues to enrich the lives of patients, families, visitors, and staff. A highlight of the programme, supported by an NHS Charities Together grant, is Fresh Arts on Referral, an innovative social prescribing programme that uses the power of art to build self-esteem and peer support networks of patients with long-term health conditions.

Staff wellbeing & training: £382k

Support for Medical Support Workers (MSW) programme £81k

A framework of support devised to meet the learning needs and psychological wellbeing of internationally trained doctors – many of whom have been displaced from Myanmar – who joined North Bristol NHS Trust as part of the nationally funded MSW programme.

Menopause for Managers: Train the Trainers Course £5k

A train the trainer course to equip managers and leaders across all divisions with a deeper understanding of menopause in the workplace. The course will enable attendees to train people managers in the Trust, helping to contribute to a more open culture of talking about the menopause, and supporting the health and wellbeing needs of our 77% female workforce.

Cutting-edge equipment: £372k

Four Vapotherms and oxygen assist modules for babies in NICU £20k

Special breathing circuits allow air to flow through a baby’s nostrils to keep their underdeveloped lungs inflated, while oxygen assist modules use automatic oxygen delivery to ensure that the baby’s oxygen saturation is maintained within a healthy range. The minimally invasive equipment means that developmental bonding between parents and babies can continue without interference.

SHC Annual Report 2022/2023

8

Report of the Trustee: Achievements and performance

Liquid Handling Robot £28k

A state-of-the-art benchtop robotics system is increasing the quality of urgent cancer testing in the South West. Automation of the testing process improves the accuracy and speed of test results, increases testing capacity, and reduces sample handling errors and the risk of contamination.

Enhancing buildings & spaces: £627k

Calm rooms to improve staff wellbeing £120k

A seminar room in the Brunel building has been transformed into a calm room equipped with comfortable sofas, mood lighting, and a reading corner. In the Women & Children’s division, a new garden room has been installed where our hardworking staff can take a break, refuel, and regroup away from the workspace.

Refurbishment of Maple Suite for bereaved families £23k

The Maple Suite is a dedicated area for bereaved families following pregnancy loss or the death of a baby. The private Suite, which enables parents to spend precious time with their baby in comforting surroundings before going home, has been updated with new furnishings such as a double bed, sofa, moses basket and a kitchenette, and the space outside renovated into a tranquil garden and seating area.

To ensure that we can continue to support our hospitals with projects like these, the sustainability of our fundraising is paramount. In-line with our grateful patients plan – part of our 2022-2024 strategy – our focus has shifted heavily towards stewardship of existing donors and, utilising the Raiser’s Edge CRM and the expertise of our Database Manager, there is a stronger emphasis on data segmentation to create relevant and donor-centric communications. Beginning in March 2022, we launched a bi-monthly email update for supporters and are planning to further tailor appeals and impact communications in the future. Aligned with this increase in supporter communications is the continuing refinement of our consent processes in which supporters are naturally opting for digital-only communications, meaning that the Charity team can contribute to North Bristol NHS Trust’s ambitious goal of Carbon Net Zero by 2030.

Our Major Gifts & Legacy Manager has been developing plans to identify further opportunities in these areas and to work with the wider team to increase the prominence of gifts in wills – a vital, if unpredictable income stream – with our supporter base. Alongside these high value activities, our community and corporate fundraising efforts have continued unabated. Individuals, families, community groups, small businesses and

SHC Annual Report 2022/2023

9

Report of the Trustee: Achievements and performance

locally based large corporations have chosen to support our hospitals and services this year, helping the Charity deliver on its promise to help our amazing NHS go further for its patients.

The successes of note over the last 12 months include:

SHC Annual Report 2022/2023

10

Report of the Trustee: Finance Review

Financial review

Income

Total income in the year was £1,695k, which is a drop of 14% on the previous year of £1,952k. The drop was mainly driven by a fall in donations due ongoing current global economic turmoil, which has created the challenging fundraising climate. However, we have started to see a shift towards the end of year.

There was also a minor drop in a total value of legacies, which continue to be important source of funding the charity. We are extremely grateful to those who remember the charity in their wills, and whose generosity plays a vital role in enhancing our hospitals.

Investment income of interest and dividends from the portfolio held at levels consistent with previous years, however we are seeing increased volatility in global markets and future investment income levels are therefore more uncertain than in the past. As we continue to focus on increasing spend, we anticipate investment income will reduce as investments are drawn down to pay for charitable schemes.

----- Start of picture text -----
Income trend (£'000)
2,125
2,059
1,978
1,151
1,021 1,002
837
692
616 580
260 242 203 228 258
54 58 8 11 10
Donations Legacies Investments Other
2018/19 2019/20 2020/21 2021/22 2022/23
----- End of picture text -----

Expenditure

Total expenditure has slightly decreased from £3,580k to £3,465k. This is mostly driven by a decrease in the amount of in-year spend on charitable activities, which has reduced from £2,652k in 2021/22 to £2,437k in 2022/23. More details on the key projects funded during the year can be found in earlier sections of this report.

SHC Annual Report 2022/2023

11

Report of the Trustee: Finance Review

----- Start of picture text -----
Expenditure trend (£'000)
2,652
2,366 2,437
2,039 2,008
829 892
721
405 466
118 85 89 99 136
Raising funds Charitable activities Other
2018/19 2019/20 2020/21 2021/22 2022/23
----- End of picture text -----

There are no uncertainties about the Charity’s ability to continue as a going concern despite the reduction in income. It is the Charity’s strategy to utilise donations made in previous years, hence, it is expected that expenditure would outweigh income in upcoming years. To facilitate this process, the reserves accumulated in the investment portfolio will be drawn upon to offset any gap between income and ongoing spend in the medium term. In 2022/23, the Charity have drawn down £2,500k from the investment fund to support the working capital.

Investments policy

The Corporate Trustee invests the Charity’s funds for growth and income using appointed investment managers. The Charity Committee regularly reviews the performance of the investments and is committed to responsible investment, which means investing in businesses that demonstrate a positive approach to the environment, society and governance (ESG). The accounting policy on investments is detailed in note 2.8 and notes that the Charity expects investments to be made in funds where the MSCI's Environmental, Social and Governance (ESG) rating is a minimum of BB. MSCI lnc. is a market leader environmental and social impact assessments for an investment market[1] . The Charity maintained a balanced portfolio, where the equity investments in the portfolio remains between 35-55% through the year as per set out target.

In order to maximise income potential, the Charity invests to generate both interest and dividends. To achieve this, an official pooling scheme is operated for investments through expert investment managers (Evelyn Partners).

1 For mor details please visit: www.msci.com.

SHC Annual Report 2022/2023

12

Report of the Trustee: Finance Review

There was a £727k reduction in valuation of investments during the year (2021/22 £404k gain). This was driven by a significant spike in the inflation in the last couple of years and increase in interest rates, which resulted in a falling of equity market. At the same time, the government security markets also experienced a fall in valuations, which was driven by global factors as well as UK-specific political events. The overall fund performance since initiation is still above the benchmark and inflation target including both realised and unrealised gains, but a medium- and short-term underperformance needs to be recognised.

Under the Trustee Investment Act 1961 and the Trustee Act 2000, the Charity as a corporate body is empowered to invest in certain categories of investments. North Bristol NHS Trust Charitable Funds make investments in accordance with these Acts.

Funds

The total funds carried forward at 31 March 2023 are £8,372k (31 March 2022: £10,869k). The structure of funds is as per graph below.

SHC Annual Report 2022/2023

13

Report of the Trustee: Finance Review

The Charity holds £31k (31 March 2021: £31k) in a permanent endowment fund which represents donations made where the donor requested that the capital be invested, remain unspent and the income earned on the capital used by the charity. Income earned on this fund is recognised against General Fund. Any market value gains or losses are recognised within the General Fund, which ensures the capital balance is maintained.

There are a number of restricted funds where the donor restricts the purpose for which the fund can be used. These totalled £1,170k at 31 March 2023 (31 March 2022: £1,132k).

Unrestricted funds include the General Fund and funds designated for a specific purpose by the Corporate Trustee. Unrestricted funds totalled £7,171k, a decrease of £2,535k on the previous year, of which £637k related to the downwards valuation of investments for the year. Total gains of £986k have been placed in a separate Investment revaluation reserve in order to protect General Funds from the ups and downs of stock market investments.

Designated funds are unrestricted funds and designated by the Corporate Trustee for particular purposes and may include those wishes indicated by a donor. Designated funds totalled £6,103k, a decrease of £1,224k on the previous year.

Total expenditure commitments from the reserves as at 31[st] March 2023 were £2,367k.

Reserves Policy

The Charity receives income in the form of donations and bequests/legacies. This income is banked when it is received. By its nature, it is difficult to predict in advance the amount of income that the Charity is likely to receive. Therefore, it is essential that the Charity maintain sums of money on reserve to meet its requirements and to act as a buffer against stock market fluctuations.

It is the policy of the Corporate Trustee to retain between 10% - 20% of the value of the Charity's Investment portfolio as unrestricted reserves. The value of the Charity’s unrestricted reserves, including investment revaluation reserve, as at 31 March 2023 were £1,068k. The reserves held at 31st March 2023 were 15%, which is calculated as follows:

Unrestricted funds held in reserve: £82k
Investment revaluation reserves: £986k
Total Reserve: £1,068k
Total value of Investment Portfolio: £7,341k
Reserve/Investment Portfolio: 15%
Target: 10%-20%

SHC Annual Report 2022/2023

14

Report of the Trustee: Finance Review

Principal risks and uncertainties

The Charity has identified and examined all major risks to which it is exposed and systems have been established to mitigate these risks.

The main identified financial risks are that investments are not properly safeguarded, investments are subject to stock market fluctuations, and inappropriate expenditure may be made (too high, too low or not properly authorised). The investment performance is closely monitored by the Southmead Hospital Charity Committee and a reserve is maintained in accordance with the Reserves Policy. Expenditure is covered by strict authorisation rules following approval of annual spending plans.

Sustainability

The Corporate Trustee would like to state its commitment to reduce both greenhouse gas emissions and energy consumption; both in the Charity costs it incurs and the charitable expenditure it seeks to fund. As the Charity is unincorporated, reporting within our Annual Report under the Streamlined Energy and Carbon Reporting (SECR) requirements is not necessary.

SHC Annual Report 2022/2023

15

Report of the Trustee: Future plans

Our future plans

We have had an incredibly busy and rewarding year at Southmead Hospital Charity, but we have more still to do. During the next 12 months we will:

The Charity’s plans are ambitious, and together with our dedicated supporters, Corporate Trustee, staff and charity partners, we can ensure a lasting legacy of a World-class National Health Service in the South-West.

In the short to medium term, the fundraising team will work on a number of priorities to improve engagement, grow fundraising across our current five key areas: research; patient support & wellbeing; staff wellbeing & training; equipment and buildings & spaces. In the longer term, the Charity, working with NBT’s senior team, will explore Trust priorities for potential options for the next large campaign to benefit from philanthropic support. To support this, our donor activity will focus on building and cultivating meaningful, strategic philanthropic relationships with High-Net-Worth individuals, corporates and trusts.

Operationally we will continue to work with our Fund Holders and divisional teams to increase spend across NBT adhering to donor wishes and therefore benefitting more projects in a timely manner. With the introduction of a new Charity database and reporting system we will focus on using data and business planning to actively grow the Charity and enable us to present evidence-based income and expenditure reports to the Charity Committee and Corporate Trustee.

SHC Annual Report 2022/2023

16

Report of the Trustee: Structure, governance and Charity management

Structure, governance and Charity management

Registration with the Charity Commission

North Bristol NHS Trust Charitable Funds is registered with the Charity Commission number 1055900, under trust deed, dated 20 May 1996. The principal office is based in Kendon House, Southmead Hospital, Bristol, BS10 5NB.

Charitable funds received by the Charity are accepted, held and administered as funds and property held on trust for purposes relating to the health service in accordance with the National Health Service Act 2006 and the National Health Service and Community Care Act 1990 and these funds are held on trust by the corporate body.

Southmead Hospital Charity Committee

North Bristol NHS Trust (NBT) is the Corporate Trustee of Southmead Hospital Charity governed by the law applicable to Trusts, principally the Trustee Act 2000 and the Charities Act 2011. Membership of the Board of the Trust is made up of those appointed positions of non-executive directors, associate non-executive directors, executive directors and non-voting executive directors. Member names can be found on pages 41 and 42.

In accordance with guidance from the Department of Health & Social Care, the Charity also administers funds held on trust on behalf of Bristol, North Somerset and South Gloucestershire Integrated Care Board (BNSSG ICB).

The authority to administer and manage NBT’s charitable funds has been delegated by the NBT’s Board to Southmead Hospital Charity Committee. Membership of the Committee is made by appointment by the Corporate Trustee and names can be found on page 42. Appropriate guidance issued by the Fundraising Regulator, Charity Commission and Information Commissioner’s Office concerning charity law and the role and responsibilities of the Corporate Trustee have been made available to members of the Committee.

The Committee meets on a quarterly basis and its responsibilities are to:

SHC Annual Report 2022/2023

17

Report of the Trustee: Structure, governance and Charity management

Terms of Reference

The Corporate Trustee of NBT approves the Terms of Reference for Southmead Hospital Charity Committee. These terms act as the governing document for the Charity and all funds held therein, in conjunction with the Trust Deed.

Management

Day–to-day running of the charity is carried out by the Senior Leadership Team, consisting of three paid members of staff, and included the Director of Southmead Hospital Charity, the Head of Fundraising and the Head of Fundraising Operations. The Director reported directly to one of the Executive Board members of NBT to ensure management of the Charity is in line with agreed plan by the Southmead Hospital Charity Committee.

All Charity Staff members are employed on NHS Agenda for Change grading and remuneration system, which means their roles and pay aligned to other similar roles within the NHS.

Charity staff

Southmead Hospital Charity team members are employed by NBT to raise funds, promote and administer funds on behalf of the Corporate Trustee. Staff members work with the Association of NHS Charities, Fundraising Regulator, the Charity Commission, Fund Holders, donors and the Southmead Hospital Charity Committee. Whilst employed by NBT, the employment costs of these staff applicable to their involvement in the work of the Charity are charged to the Charity.

The Corporate Trustee delegates the responsibility of authorising expenditure charged to the Charity in accordance with detailed Scheme of Delegation.

Auditor

An independent audit is conducted annually to fulfil the charity’s legal obligations and for the Corporate Trustee to ensure financial statements have been properly prepared and give a true and fair view. The auditor's report to the Corporate Trustee is given on pages 22 to 26.

SHC Annual Report 2022/2023

18

Report of the Trustee: Structure, governance and Charity management

Statement as to disclosure of information to auditors

The Corporate Trustee has taken all the necessary steps to make themselves aware of any relevant audit information and to establish that the auditors are aware of that information. As far as the Corporate Trustee is aware, there is no relevant audit information of which the charity's auditor is unaware.

Fundraising

To achieve our charitable aims we need to raise vital income through fundraising. In all cases we ensure we meet the standards and obligations that must be met in all our fundraising activities.

The Charity ensures that all fundraising expenditure will be to maximise our return on investment whilst maintaining the best possible relationship with our donors and supporters. In ensuring we focus on both raising funds across all income streams and to improve our governance, business planning and compliance with regulation, our fundraisers are staff members. No fundraising is undertaken by commercial participators for the Charity. We do acknowledge that some of our supporters seek to raise money by undertaking selfdetermined events and challenges voluntarily and other organisations that support our work may also donate to the charity; and we are grateful for their support. Fundraisers are provided with clear guidelines of best practice in order to ensure fundraising activities are safe and legal.

The Charity is a member of the NHS Charities Together (NHSCT) who ensure that we are kept informed and fully updated on all current and developing issues. Concerns are highlighted and knowledge is shared with similar organisations. NHSCT raises funds to which applications for grants can be made; though there is no agreement in place for funds to be automatically forwarded to the Charity.

The Charity subscribes to the Fundraising Regulator and supports the Code of Fundraising Practice. We abide by their regulations and principles of best practise. There were no incidents of non-compliance during the year. We are also registered with the Fundraising Preference Service, which enables individuals to opt out from receiving fundraising communications from us should they choose to do so.

Southmead Hospital Charity Committee approves the annual income target and operating expenditure budget for the year. The Charity’s senior leadership team utilises the resources allowed in the expenditure budget to deliver against the team’s income target. The Charity reports on a quarterly basis to the Charity Committee and Corporate Trustee. If the Charity fails to generate its expected return on investment the Charity Director will recommend strategies to improve the return and implement alternative fundraising plans.

While we do everything we can to provide the best possible service, we are aware we may not always get it right. The Charity has an agreed complaints procedure, and complaints log, and staff are required to bring any

SHC Annual Report 2022/2023

19

Report of the Trustee: Structure, governance and Charity management

complaint to the attention of the Senior Leadership Team and to record the complaint on the Charity’s database. In 2022/23 he Charity has received six complaints in total, of which one was related to fundraising activity (three during 2021/2022, of which one related to fundraising). The fundraising complaint during 2022/23 was a minor complaint, that was quickly resolved and resulted in us updating our fundraising guidelines for third party volunteer fundraisers.

As part of NBT, the Charity has approved policies for safeguarding and privacy, which follow the strict NHS guidelines around safeguarding. The Charity’s website includes our privacy policy and a commitment to ensuring that supporters are in control of how communications with them are managed. In compliance with the Data Protection Act and the Information Commissioner’s guides and code, we are responsive to all communications preference updates and act according to the wishes of our supporters on how their personal data is handled.

The patients of NBT are the ultimate beneficiaries of the Charity and NBT is a related party by virtue of being the Corporate Trustee of the Charity. By working in partnership with NBT, the charitable funds are used to best effect. When deciding upon the most beneficial way to use charitable funds, the Corporate Trustee reviews to the main activities, objectives, strategies and plans of NBT.

We remain indebted to the work of the League of Friends affiliated to each of our hospitals, who raise thousands of pounds each year and contribute towards the purchase of major items of medical equipment.

Public Benefit Statement

This Annual Report has been prepared with regard to public benefit guidance published by the Commission and complies with section 17 of the Charities Act 2011. The Corporate Trustee confirms that they have had regard to the Charity Commission’s general guidance on public benefit when reviewing the Charity’s aims and objectives, and in planning activities and setting policies and priorities for the year ahead.

Southmead Hospital Charity exists to enhance the services for patients and to provide additional facilities for staff and funding for research, in addition to that which the Trust is normally able to provide. Throughout this report we illustrate how our work furthers our charitable purposes and the significant benefits it brings to communities and individuals.

The Corporate Trustee refers to the Charity Governance Code and seeks to implement the recommendations in continually aiming for best practice and ongoing improvement.

SHC Annual Report 2022/2023

20

Report of the Trustee: Statement of Trustee responsibilities

Statement of Trustee’s responsibilities in respect of the accounts

The Corporate Trustee is responsible for preparing the Trustees' Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England and Wales requires the Corporate Trustee to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for that period. In preparing these financial statements, the Corporate Trustee is required to:

The Corporate Trustee is responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and enable it to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008, the National Health Service Act 2006 and the provisions of North Bristol NHS Trust Charitable Funds’ procedures. It is also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The Corporate Trustee is responsible for the maintenance and integrity of the Charity's finances and any published information. The Corporate Trustee confirms to the best of its knowledge and belief it has compiled with the above requirements in preparing the accounts.

The Corporate Trustee is responsible for the maintenance and integrity of the Charity and financial information included on the Charity's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

By Order of the Corporate Trustee

Signed and authorised for issue on behalf of the Corporate Trustee on 30 November 2023:

Richard Gaunt, Chair

Glyn Howells, Chief Finance Officer

SHC Annual Report 2022/2023

21

Report of the Trustee: Independent auditor’s report

Independent Auditor’s Report to the Trustees and Members

For the Year Ended 31 March 2023

Opinion

We have audited the financial statements of the North Bristol NHS Trust Charitable Funds (the ‘charity’) for the year ended 31 March 2023, which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

SHC Annual Report 2022/2023

22

Report of the Trustee: Independent auditor’s report

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement set out on page 21 the trustees are responsible for the preparation of financial statements which give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

SHC Annual Report 2022/2023

23

Report of the Trustee: Independent auditor’s report

In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under the Charities Act 2011, s. 144 and report in accordance with regulations made under the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements, as a whole, are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

We assessed the susceptibility of the charity’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

SHC Annual Report 2022/2023

24

Report of the Trustee: Independent auditor’s report

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of noncompliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to

SHC Annual Report 2022/2023

25

Report of the Trustee: Independent auditor’s report

the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Albert Goodman LLP

Statutory Auditor

Goodwood House

Blackbrook Park Avenue

Taunton

TA1 2PX

Date: 05/12/2023

Albert Goodman LLP is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

SHC Annual Report 2022/2023

26

Report of the Trustee: Statement of Financial Activities

Statement of financial activities

for the year ended 31 March 2023 (incorporating an income and expenditure account)

Note
INCOME AND EXPENDITURE
Income and endowments from:
Donations
3
Legacies
Other trading activities
Investments
4
Other
Total income
Expenditure on:
Raising funds
5
Charitable activities
6
Support costs
7
Total expenditure
Net (expenditure)/income before
gains on investments
Net gains / (losses) on investments
10
Net (expenditure)/income
8
Transfers between funds
Net movement in funds
Funds at the start of the year
14
Funds at the end of the year
14		 Unrestricted
£’000
Restricted
£’000
Permanent
endowment
£’000
Year ended
31 Mar 2023
£’000
Year ended
31 Mar 2022
£’000
671
166
-
837
1,021
457
123
-
580
692
17
-
-
17
1
226
32
-
258
228
3
-
-
3
10
1,374
321
-
1,695
1,952
883
9
-
892
829
2,295
142
-
2,437
2,652
136
-
-
136
99
3,314
151
-
3,465
3,580
(1,940)
170
-
(1,770)
(1,628)
(637)
(90)
-
(727)
404
(2,577)
80
-
(2,497)
(1,224)
42
(42)
-
-
-
-
(2,497)
(1,224)
9,706
1,132
31
10,869
12,093
7,171
1,170
31
8,372
10,869

The notes on pages 30 to 42 are an integral part of these financial statements.

All activities relate to continuing operations.

SHC Annual Report 2022/2023

27

Report of the Trustee: Balance Sheet

Balance sheet as at 31 March 2023

Charity registration number: 1055900

Note
Fixed assets
Investments
4, 10
Current assets
Debtors
11
Cash at bank and in hand
Liabilities
Creditors: amounts falling due
within one year
12
Net current assets
Net assets
13
The funds of the charity
Permanent endowment fund
Restricted funds
Unrestricted funds
General funds
Designated funds
Funds at the end of the year
14		 31 Mar 2023
£’000
31 Mar 2022
£’000
7,341
10,347
7,341
10,347
184
189
1,187
1,071
1,371
1,260
(340)
(738)
1,031
522
8,372
10,869
31
31
1,170
1,132
82
802
7,089
8,904
8,372
10,869

The financial statements on pages 27 to 42 were approved by the Corporate Trustee on 30 November 2023

and were signed on its behalf by

……………………………………………………….

Glyn Howells, Chief Financial Officer

SHC Annual Report 2022/2023

28

Report of the Trustee: Cash flow statement

Cash flow statement

For the year ended 31 March 2023

Cash flows from operating activities
Net cash (used in) operating activities
Cash flows from investing activities
Investment income
Proceeds from the sale of fixed asset investments
Purchase of fixed asset investments
Net cash provided by investing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year		 31 Mar 2023
£’000
31 Mar 2022
£’000
(2,417)
(1,421)
258
228
3,826
2,042
(1,551)
(1,787)
2,553
483
116
(938)
1,071
2,009
1,187
1,071

Notes to the cash flow statement

Reconciliation of net income/(expenditure) to net cash flow from operating activities

Reconciliation of net income/(expenditure) to net cash flow from operating activities
Net income for the year
Adjustments for:
Net (gain) / loss on investments
Investment income
(Increase)/decrease in debtors
Increase/(decrease) in creditors
Net cash (used in) operating activities
Analysis of cash and cash equivalents
Cash at bank and in hand
Total cash and cash equivalents		 31 Mar 2023
£’000
31 Mar 2022
£’000
(2,497)
(1,224)
727
(404)
(258)
(228)
5
(34)
(394)
469
(2,417)
(1,421)
31 Mar 2023
£’000
31 Mar 2022
£’000
1,187
1,071
1,187
1,071

SHC Annual Report 2022/2023

29

Report of the Trustee: References and administration details

Notes to the accounts

1. General information

North Bristol NHS Charitable Funds is a charity registered in England and Wales under a declaration of trust, (charity number 1055900) operating under the name Southmead Hospital Charity. As such it is registered with the Charity Commission in the United Kingdom as a charity. The Charity's registered office is Southmead Hospital, Southmead Road, Bristol, BS10 5NB. This is the same as North Bristol NHS Trust which is its parent entity.

The Charity is considered a wholly controlled subsidiary of North Bristol NHS Trust as the Board of North Bristol NHS Trust is, as a corporate body, the trustee of North Bristol NHS Trust Charitable Funds. North Bristol NHS Trust's purpose is to improve healthcare in the region in which it treats patients.

The financial statements have been prepared in compliance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102).

2. Accounting policies

A summary of the more important accounting policies, which have been applied consistently, is set out below.

2.1 Basis of preparation

The financial statements have been prepared under the historic cost convention, as modified for the revaluation of certain investments.

The charity constitutes a public benefit entity as defined by FRS102.

The financial statements are prepared in sterling (GBP) which is the functional currency of the charity and is rounded to the nearest £’000. Comparative information relates to the year ended 31 March 2022.

The Corporate Trustee is confident that the level of unrestricted reserves and income mean the charity has a secure future. There are no material uncertainties about the charity’s ability to continue. The accounts have been prepared on a going concern basis.

2.2 Critical accounting judgements and estimates

The preparation of the financial statements requires management to make some judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date, the amounts reported for income and expenditure and the disclosures made in the financial statements. Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. However, the nature of estimation means that actual outcomes could differ from those estimates.

The main assumptions in these accounts relate to accounting for accruals where requests and intentions to spend funds were not sufficiently progressed to recognise their values; and then also making judgements informed by the documentation provided by and expertise of Evelyn Partners, professional investment managers, in relation to the valuation of the Charity’s investment portfolio (see 2.8 below). Also at the year end, as stated in note 17, a critical judgement was made in relation to legacy income and due to uncertainty over the value a contingent asset has been disclosed.

2.3 Income

a) All incoming resources are included in full in the Statement of Financial Activities as soon as the following three factors can be met.

i) Entitlement - arises when a particular resource is receivable or the Charity's right becomes legally enforceable;

ii) Probability – it is more likely than not that the economic benefits associated with the transaction or gift will flow to the charity.

SHC Annual Report 2022/2023

30

Report of the Trustee: References and administration details

iii) Measurement - the monetary value or amount of the income can be measured reliably, and, applying matching principles, the costs

incurred for the transaction and the costs to complete the transaction can be measured reliably.

b) Income received from the investment of endowment funds is treated as unrestricted.

c) Legacies are accounted for as incoming resources once the receipt of the legacy becomes probable. This will be once confirmation has

been received from the representatives of the estate that payment of the legacy or transfer of property is likely to be made and a reliable

estimate of the value can be made and once all conditions attached to the legacy have been fulfilled.

d) Gifts in kind:

i) Assets given for distribution by the Charity are included in the Statement of Financial Activities only when distributed.

ii) Assets given for use by the Charity (e.g. property for its own occupation) are included in the Statement of Financial Activities as

incoming resources when receivable.

iii) Gifts made in kind but on trust for conversion into cash and subsequent application by the Charity are included in the accounting

period in which the gift is sold.

In all cases the amount at which gifts in kind are brought into account is either a reasonable estimate of their value to the Charity or the amount actually realised.

In accordance with the Charities SORP (FRS102), no value is ascribed to the unpaid contributions of time and skills provided by volunteers due to the difficulty in attributing an economic value.

2.4 Resources expended

The Charity's accounts are prepared in accordance with the accruals concept. All expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party

a) The costs of generating funds are the costs associated with generating income for the Charity. These will include the costs associated with appeals, printing, publicity and investment management together with appropriate salary costs.

b) Activities in the furtherance of the Charity's objectives are accounted for on an accruals basis where the conditions for their payment have been met or where a third party has a reasonable expectation that they will receive the grant. This includes grants made to NHS bodies.

c) Support costs of the Charity include costs incurred by the finance department of North Bristol NHS Trust. These are accounted for on an accruals basis and comprise all costs of the Charity and its compliance with regulation and good practice.

d) Governance costs include costs related to statutory audit.

2.5 Realised and unrealised gains and losses

All gains and losses are taken to the Statement of Financial Activities as they arise. Realised gains and losses on investments are calculated as the difference between sales proceeds and opening market value (or date of purchase if later). Unrealised gains and losses are calculated as the difference between market value at the year end and opening market value (or purchase price if acquired during the year). The Charity has made judgements in making these calculations which are informed by the documentation provided by and expertise of Evelyn Partners, professional investment managers in relation to the valuation of the Charity’s investment portfolio (see 2.8 below).

SHC Annual Report 2022/2023

31

Report of the Trustee: References and administration details

2.6 Apportionment

Dividends, interest and governance costs are apportioned monthly to fundraising income fund. Realised and unrealised gains and losses held on reserve are apportioned to restricted and unrestricted funds. Central support and fundraising costs have been allocated to fundraising income fund.

2.7 Fund Accounting

a) Restricted funds are to be used for specific purposes as laid down by the donor and are legally restricted to that purpose. Expenditure which meets these criteria is charged to the fund.

b) Unrestricted funds are donations and other incoming resources received or generated for the charitable purposes, within the overall objects of the Charity.

c) Designated funds are unrestricted funds and designated by the Corporate Trustee for particular purposes and may include those wishes indicated by a donor.

d) The permanent endowment funds held are those which can only be used to generate income via investments and which cannot be spent. Any market value gains or losses are recognised within unrestricted funds, which ensures the capital balance is maintained. The income is treated as unrestricted.

Activities in the furtherance of the Charity's objectives are accounted for on an accruals basis where the conditions for their payment have been met or where a third party has a reasonable expectation that they will receive the grant. This includes grants made to NHS bodies.

Support costs of the Charity include costs incurred by the finance department of North Bristol NHS Trust in supporting the Charity financial management and reporting. These are accounted for on an accruals basis and comprise all costs of the Charity and its compliance with regulation and good practice. Governance costs include costs related to statutory audit.

2.8 Investments

Fixed asset investments are held to generate income maximising value in the short term cash holdings in advance of charitable expenditure. Listed investments are stated at market value. The Charity has made judgements informed by the documentation provided by and expertise of Evelyn Partners, professional investment managers, in relation to the valuation of the Charity’s investment portfolio.

An official pooling scheme is operated for investments and is operated by Evelyn Partners, (previously Smith & Williamson before merger) acting as expert Investment Managers for the Charitable Funds. They are instructed to maintain a balanced portfolio of holdings with a criteria where the equity investments in the portfolio should be between 35-55%. The portfolio should include no direct investment in tobacco companies and no investment in Russian Securities. Where possible, the investments in equity and fixed income should only be made in funds where the underlying manager is a signatory to the United Nations Principles for Responsible Investment (UNPRI), or if they are intending to or in the process of becoming a signatory. The Charity expects investments to be made in funds where the MSCI's Environmental, Social and Governance (ESG) rating is a minimum of BB. MSCI lnc. is a market leader in assessment of environmental and social impact assessment for an investment market.

Short term balance monies are held in a current account with our bank until such time as they are needed to meet expenditure requirements. As the balances are dependent on the income received on a day to day basis, they fluctuate in accordance with the income received. In addition to this, cash is held with Evelyn Partners to enable them to purchase and sell investments in line with the investment policy.

Under the Trustee Investment Act 1961 and the Trustee Act 2000, the Charity as a corporate body, is empowered to invest in certain categories of investments. The Charity makes investments in accordance with this Act.

SHC Annual Report 2022/2023

32

Report of the Trustee: References and administration details

2.9 Reserves Policy

It is the policy of the Corporate Trustee to retain on reserve a minimum of 10% and up to 20% of the value of the Charity's investment portfolio in the form of unrealised and realised gains. In addition, the Charity holds a minimum cash balance of six months operating costs as a cash reserve.

The Charity’s Financial reserves mainly comprise of cash and investment funds. The main purpose of these reserves is to maintain sufficient finance for the Charity’s planned future operations and activities. The aim of the reserves is to protect the Charity from unforeseen financial challenges, while making funds available for investment in future activities.

The Investment funds and Cash at bank and in hand are apportioned across the category of restricted and unrestricted funds based on the fund value in the statement of financial activities.

Commitment forecasts are produced by the Charity in order to assist with the Charity's overall financial plans.

The level of reserves and expenditure commitments are reviewed quarterly to ensure that the Charity expenditure is in line with income and reduces the level of reserves held.

2.10 Stock

The Charity had £nil value of stock as at 31st March 2023. All items of donated stock were distributed during the financial year. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.

2.11 Debtors

Trade and other debtors are recognised at the settlement amount due. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.12 Cash at bank and in hand

Cash and cash equivalents comprise cash on hand and on demand bank deposits, cash held by the Trust on the Charity's behalf and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk to changes in value.

2.13 Creditors and provisions

Creditors are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors are normally recognised at their settlement amount after allowing for any trade discounts due.

2.14 Financial instruments

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at settlement value and subsequently measured at their market value.

SHC Annual Report 2022/2023

33

Report of the Trustee: References and administration details

3. Income from donations
Donations
Grants
Other		 Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2023
£’000
Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2022
£’000
470
33
503
487
-
487
46
133
179
302
64
366
155
-
155
168
-
168
671
166
837
957
64
1,021

During the 2021/22 year and included above is a restricted grant from NHS Charities Together £64k for staff well-being.

4. Investment income
Dividends and listed security other
income
Interest receivable		 Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2023
£’000
Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2022
£’000
106
15
121
108
-
108
120
17
137
120
-
120
226
32
258
228
-
228
5. Costs of raising funds
Fundraising salaries
Fundraising costs
Investment charges		 Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2023
£’000
Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2022
£’000
672
-
672
660
-
660
147
-
147
107
-
107
64
9
73
62
-
62
883
9
892
829
-
829

6. Expenditure on charitable activities

Research
Patient and family wellbeing
Staff support and training
Equipment
Buildings and spaces		 Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2023
£’000
Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2022
£’000
370
62
432
127
-
127
593
31
624
388
9
397
355
27
382
1,757
40
1,797
372
-
372
320
-
320
605
22
627
11
-
11
2,295
142
2,437
2,603
49
2,652

SHC Annual Report 2022/2023

34

Report of the Trustee: References and administration details

7. Support costs
Finance service costs
Governance costs:
Audit services		 Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2023
£’000
Unrestricted
£’000
Restricted
£’000
Year ended
31 Mar 2022
£’000
120
-
120
80
0
80
16
-
16
19
0
19
136
-
136
99
0
99

Governance costs, excluding audit services and other support costs are borne by the Corporate Trustee. Audit services are stated gross of VAT.

8. Net (expenditure) for the year


Net (expenditure) for the year
This is stated after charging:
Auditor’s remuneration: Audit services (net of VAT)		 Year ended
31 Mar 2023
£’000
Year ended
31 Mar 2022
£’000
(2,497)
(1,224)
(14)
(14)
9. Staff costs
Wages and salaries
Social security costs
Pension costs: defined contribution scheme		 Year ended
31 Mar 2023
£’000
Year ended
31 Mar 2022
£’000
538
528
60
56
74
76
672
660

Southmead Hospital Charity team members are employed by North Bristol NHS Trust, with costs of employment recharged to the Charity in full.

Staff numbers
Cost of raising funds:
Average headcount
Charitable activities:
Average headcount
Total
Average headcount		 Year ended
31 Mar 2023
Number
Year ended
31 Mar 2022
Number
10
13
3
2
13
15

No representatives of the Corporate Trustee received any emoluments during the year from the Charity for their roles as Corporate Trustee representatives (2021/22: none). During the year, no out-of-pocket expenses (2021/22: none) were paid from the Charity. The total cost of the Corporate Trustee expenses was higher than this, but some representatives chose to waive their expenses. The Corporate Trustee does not consider it economically worthwhile to collect data on waived expenses so the value of this has not been quantified.

SHC Annual Report 2022/2023

35

Report of the Trustee: References and administration details

The key management personnel of the Charity comprise the Corporate Trustee representatives, who are not remunerated for these roles and give freely of their time, and the Charity Director, Head of Fundraising and Head of Fundraising Operations. The total employee remuneration of key management personnel (including national insurance) was £168k (2021/22: £183k) plus pension contributions of £22k (2021/22: £24k).

Employees received emoluments (excluding national insurance and pension contributions) in excess of £60,000 within the following ranges:

Year ended Year ended
Banding: 31 Mar 2023 31 Mar 2022
Number Number
£60,001 - £70,000 - -
£70,001 - £80,000 1 1
£80,001 - £90,000 - -
10. Investments
Market value at start of year
Unrealised (losses)
Realised gains
Equalisation
Sale of investments
Purchase of additional investments
Market value at end of the year
Historical cost at end of the year
Fixed interest securities – UK
Equity shares – UK
Equity shares – overseas
Property funds
Alternative investments
Total		 Year ended
31 Mar 2023
£’000
Year ended
31 Mar 2022
£’000
10,347
10,198
(1,363)
(149)
633
553
-
(1)
(3,827)
(2,042)
1,551
1,788
7,341
10,347
7,220
8,770
2,422
2,810
1,182
1,607
1,691
3,046
796
1,328
1,250
1,556
7,341
10,347

£2,500k of capital drawdowns were received by the Charity during 2022/23 (£nil during 2021/22).

Reconciliation to SOFA
Unrealised gains/(losses) on investments
Realised gains on investments
Equalisation recognised within cash position
Total gains / (losses) per SOFA		 Year ended
31 Mar 2023
£’000
Year ended
31 Mar 2022
£’000
(1,363)
(149)
633
553
3
-
(727)
404

SHC Annual Report 2022/2023

36

Report of the Trustee: References and administration details

11. Debtors

11. Debtors
Trade debtors
Accrued income		 2023
£’000
2022
£’000
178
186
6
3
184
189

12. Creditors: amounts falling due within one year

Trade creditors
Amounts owed to parent		 2023
£’000
2022
£’000
(186)
(472)
(154)
(266)
(340)
(738)

13. Analysis of net assets

Permanent
Unrestricted Designated Restricted endowment Total Total
funds funds funds funds 2023 2022
£’000 £’000 £’000 £’000 £’000 £’000
Investments 73 6,211 1,026 31 7,341 10,347
Net current assets 9 878 144 - 1,031 522
Net assets 82 7,089 1,170 31 8,372 10,869
Permanent
Unrestricted Designated Restricted endowment Total Total
funds funds funds funds 2022 2021
£’000 £’000 £’000 £’000 £’000 £’000
Investments 859 8,435 1,022 31 10,347 10,198
Net current assets (57) 469 110 0 522 1,895
Net assets 802 8,904 1,132 31 10,869 12,093

SHC Annual Report 2022/2023

37

Report of the Trustee: References and administration details

14. Movements in funds

At 31 Mar Incoming Outgoing Transfers Gains/ At 31 Mar
2022 resources Resources (losses) 2023
£’000 £’000 £’000 £’000 £’000 £’000
Permanent endowment fund 31 - - - - 31
Restricted funds:
Multiple Sclerosis patient care 185 5 (26) - (13) 151
Multiple Sclerosis 181 5 (1) - (14) 171
Vasospasm Research - 101 - - (4) 97
Breast Care Centre 101 3 (12) - (7) 85
BUI Oncology Urology Research
and Treatment		 92 2 (1) (42) (5) 46
Staff well-being support 64 4 (36) - (4) 28
BUI Oncology Urology 61 2 - - (5) 58
Dreams and wishes 53 1 - - (4) 50
Mum’s the word appeal 53 1 - - (4) 50
Vascular research 45 1 (41) - (2) 3
Other funds: balances less than
£40k		 297 196 (34) - (28) 431
Total restricted funds 1,132 321 (151) (42) (90) 1,170
Unrestricted funds:
Designated funds:
Legacies 940 - (214) - - 726
Intensive Care Unit 929 33 (388) - - 574
Springboard research 414 - (166) 26 - 274
Robotic Microscope 320 50 - 101 - 471
Dialysis 294 5 (61) - - 238
Renal 278 18 (19) 5 - 282
Helipad 224 - (224) - - -
Multiple Sclerosis Research 204 - (20) - - 184
Medicine Cardiology 168 - (1) 1 - 168
Parkinson's Research 160 1 (1) 1 - 161
Fresh Arts 155 36 (138) 10 - 63
Radiology Scanning 119 - (15) - - 104
Bacteriology Research 118 - (26) - - 92
Vascular 116 - 1 - - 117
BUI Urology 113 1 (1) - - 113
Dementia 111 (57) - (13) - 41
Other designated funds: balances
less than £110k		 2,664 386 (515) (40) - 2,495
General unrestricted funds 802 901 (1,462) (159) - 82
Investment revaluation fund 1,577 - (64) 110 (637) 986
Total unrestricted funds 9,706 1,374 (3,314) 42 (637) 7,171
Total funds 10,869 1,695 (3,465) - (727) 8,372

SHC Annual Report 2022/2023

38

Report of the Trustee: References and administration details

The permanent endowment fund represents donations made where the donor requested that the capital be invested, remain unspent and the income earned on the capital used by the charity. Income earned on this fund and any market value gains or losses are recognised in unrestricted funds, which ensures the capital balance on the permanent endowment fund is maintained.

Restricted funds are funds for which the donor has specifically restricted the purpose for which it can be used.

Designated funds are unrestricted funds and designated by the Corporate Trustee for particular purposes and may include those wishes indicated by a donor.

The General funds represent those unrestricted funds that are freely available for use on the general running costs of the charity and also for delivering centrally managed projects of charitable activities.

The majority of the funds above are held for the specific benefit of the patients and staff of the listed service of the North Bristol NHS Trust.

The Investment revaluation fund, set up in 2021/22 by transfer from General funds, comprises funds set aside following gains on investments. This reserve protects General funds from negative fluctuations in equity values.

Out of the total funds balance of £8,372k (2021/22: £10,869k), a total of £7,341k (2021/22: £10,347k) is held in the investments, which means the Charity will need to sell investments to facilitate any major expenditure and to support working capital over the long-term. The total drawn down from investments during the 2022/23 financial year was £2,500k (2021/22: £nil).

15. Capital commitments

At 31 March 2023 the values of capital commitments that were authorised and contracted for were £nil (2021/22 £nil).

16. Related party transactions and transactions with the Corporate Trustee

During 2022/23 there were no related party transactions with the Directors of the Trust Board of North Bristol NHS Trust (2021/22: £nil).

Details of the remuneration of representative of Corporate Trustees are included in the accounts of North Bristol NHS Trust.

The Charity has made revenue and capital payments to North Bristol NHS Trust where the representatives, as listed earlier, of the Trustee are also members of the Trust. All operations of the Charity are directly linked with North Bristol NHS Trust. As a result, the Charity is considered as part of the Group for the purpose of consolidated accounts.

The value of the transactions made directly with the Corporate Trustee in line with the objects of the Charity in supporting the work of the Corporate Trustee during the year was £1,536k (2021/22 £1,070k).

Southmead Hospital Charity team members are employed by North Bristol NHS Trust, with costs of employment recharged to the Charity in full.

The unsecured amounts owed to the parent body (North Bristol NHS Trust) at the year end were £154k (2021/2022 £266k) which are disclosed in note 12.

One of the Board members of NBT is also a member of the Board of Trustees of the University of Bristol, with which the charity recorded expenditure of £182k during 2022/23 (£571k during 2021/22).

17. Contingent assets

At the year end there were three contingent assets due to the charity (2021/22: £525k).

The first was estimated to be £101k at the year end. There is still uncertainty around the remaining value of the estate.

SHC Annual Report 2022/2023

39

Report of the Trustee: References and administration details

The second relates to a complex legacy estate with an estimated value of £180k. However, the valuation is caveated due to significant anticipated costs associated with renovating the property in order to achieve a saleable state and also identifying any outstanding liabilities, which are unknown as at the time of finalising these accounts.

The third contingent asset relates to a legal settlement with a supplier in respect of a refund for unused Christmas vouchers purchased for the staff of NBT. However the contract was set up between the supplier and the Trust, and as at the year end, the refund value was unknown due to ongoing challenges around a reasonable cost adjustment from the supplier. A settlement was reached in September 2023 for a value of £70k, which is expected to be transferred to the Charity from the Trust.

SHC Annual Report 2022/2023

40

Report of the Trustee: References and administration details

Reference and administration details

Bankers:

NatWest, Government Banking CST, PO Box 2027, Parklands, De Havilland Way, Horwich, Bolton, BL6 4YU

Auditor:

Albert Goodman LLP, Goodwood House, Blackbrook Park Avenue, Taunton, TA1 2PX

Investment Fund Managers:

Evelyn Partners (previously Smith & Williamson Investment Management before merger), Portwall Place, Portwall Lane, Bristol BS1 6NA

VAT Advisors:

Liaison Financial Services, Liaison Court, Vincent Road, Worcester WR5 1BW

Solicitors:

Womble Bond Dickinson (UK) LLP, 3 Temple Quay, Temple Back East, Bristol BS1 6DZ

Corporate Trustee

North Bristol NHS Trust is the sole Corporate Trustee. During the 2022/2023 year the following individuals (non-executive, associate non-executive and executive) served as members of the Trust Board.

Non-executive Directors

Michele Romaine, Chair Professor John Iredale (until 31[st] December 2022) Kelly Macfarlane Dr Jane Khawaja (from 1[st] January 2023)

Tim Gregory Kelvin Blake Richard Gaunt Professor Sarah Purdy

Associate Non-executive Directors

Sandra Harding (non-voting) (until 31[st] December 2022) Ike Anya (non-voting) (until 31[st] January 2023)

SHC Annual Report 2022/2023

41

Report of the Trustee: References and administration details

Executive Directors

Maria Kane Chief Executive Officer Steve Curry Chief Operating Officer Glyn Howells Chief Financial Officer Tim Whittlestone Chief Medical Officer Steve Hams Chief Nursing Officer Jacqui Marshall Chief People Officer (non-voting) (until 27 February 2023) Jude Gray Interim Chief People Officer (non-voting) (from 27 February 2023) Neil Darvill Chief Digital Information Officer (non-voting)

During 2022/2023 members of the Charitable Funds Committee were: -

Chair Richard Gaunt Non-Executive Director Non-Executive Members Michele Romaine Trust Chair Kelvin Blake Non-Executive Director Executive Directors Glyn Howells Chief Financial Officer Jacqui Marshall Chief People Officer (non-voting on Trust Board) (until 27 February 2023) Jude Gray Interim Chief People Officer (from 27[th] February 2023) Steve Hams Chief Nursing Officer

Key Management Personnel

Sarah Harrison Charity Director (until 7[th] March 2023) Julian Hall Head of Fundraising (until 31[st] January 2023) Sally Bennett Head of Fundraising (from 4[th] January 2023) Shiona MacPherson Head of Fundraising Operations

SHC Annual Report 2022/2023

42

For further information about Southmead Hospital Charity please contact:

Southmead Hospital Charity Kendon House

Southmead Hospital Bristol BS10 5NB

hello@southmeadhospitalcharity.org.uk

0117 414 0170

southmeadhospitalcharity.org.uk Facebook: Southmead Hospital Charity Instagram: Southmead Hospital Charity Twitter: @supersouthmead